ANDA 74147, held by Hospira. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 74147 (Metoclopramide Hydrochloride), held by Hospira, was first approved by FDA on Aug 2, 1996, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 2, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/ML · injectable;injection | Metoclopramide Hydrochloride | Discontinued |
| Dec 6, 2002 | Supplement 6Labeling | Approved | None posted |
| Feb 1, 2002 | Supplement 4Labeling | Approved | None posted |
| Feb 14, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Apr 6, 2000 | Supplement 2Labeling | Approved | None posted |
| Oct 22, 1999 | Supplement 1Labeling | Approved | None posted |
| Aug 2, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters